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ABSTRACT
Objectives: A simple and sensitive gas chromatographic method was developed and validated for simultaneous determination of acetone and 
isopropyl alcohol in paroxetine.
Methods: The separation was achieved on ZB-1, 30 m length × 0.53 mm ID, and film thickness 5 µm using a flame ionization detector (FID) with 
gradient column oven temperature program. The injection was carried out in split mode, with a split ratio of 10:1. Dimethylacetamide was selected 
as a diluent to obtain good sensitivity along with the recovery. 1-propanol was used as an internal standard which employed for area ratio method.
Results: The developed gas chromatographic method offers symmetric peak shape, good resolution of 2.3 min, and reasonable retention time for 
the solvents acetone 9.210 min and isopropyl alcohol 9.845 min. The limit of detection for acetone and isopropyl alcohol was 26.72 µg/ml and 
82.96 µg/ml, respectively. Limit of quantitation for acetone and isopropyl alcohol was 80.96 µg/ml and 251.39 µg/ml, respectively. Precision was 
0.83 and 0.63. Linearity was y = 0.0004x, R2 = 0.9988 for acetone, and y = 0.0001x+0.0021, R2 = 0.9987 for isopropyl alcohol, and accuracy along with 
robustness is performed and acceptable results were obtained.
Conclusion: The proposed, developed method was demonstrated to be simple, sensitive, linearity, accurate, and robust, hence can be used to 
determine the residual organic solvents in paroxetine drug substance and drug product.
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INTRODUCTION
Paroxetine is an antidepressant in a group of drugs called selective 
serotonin reuptake inhibitors. Paroxetine affects chemicals in the 
brain that may become unbalanced. Paroxetine (Fig. 1) is used to treat 
depression, obsessive-compulsive disorder, anxiety disorders, post-
traumatic stress disorder, and premenstrual dysphoric disorder. An 
impurity in a drug substance was defined by the International Conference 
on Harmonisation (ICH) guidelines that are any component of the drug 
substance that is not the chemical entity defined as the drug substance 
and affects the purity of active ingredient or drug substances [1]. 
Similarly, an impurity in a drug product is any component of the drug 
product that is not the chemical entity defined as the drug substance or 
an excipient in the drug product [2]. Therefore, any extraneous material 
present in the drug substance has to be considered an impurity even 
if it is inert or has superior pharmacological properties. The impurity 
profile of pharmaceuticals is of increasing importance as drug safety 
receives more and more attention from the public and the media. Several 
recent books and journal reviews address this topic and guidelines 
are available from the US and international authorities [3-10]. Most 
active pharmaceutical ingredients (APIs) are produced by organic 
chemical synthesis. Various components, including residual solvents, 
trace amounts of inorganic, and organic components, can be generated 
during such a process.
Analysis of a residual solvent in pharmaceuticals is an important 
issue due to the potential risk to human health from the toxicity of 
many of these solvents. The amount of such solvents is, therefore, 
limited by ICH guidelines [9]. The international conference on 
harmonization recommends and limits the amount of residual 
solvents considered safe in pharmaceutically finished goods and for 
human use. The ICH has published guidelines and daily exposure 
limit of many solvents. It has classified these solvents in three 
categories depending on their toxicity. Class I solvents are known 
human carcinogens and environmental hazards, the use of these 
solvents should be avoided if at all possible. Class II solvents are 
non-genotoxic animal carcinogens or possible causative agents of 
other irreversible toxicities such as neurotoxicity or teratogenicity. 
The use of these solvents should be limited. Class III solvents are 
the solvents with the low toxic potential to man; no health-based 
exposure limit is needed. In the pharmaceutical industries, all the 
pharmaceutical products must be analyzed for residual solvent 
content, regardless of the matrix.
Gas chromatography is generally used to determine residual solvents 
due to its excellent separation abilities and low limit of detection. In 
gas chromatography, the sample is either dissolved in a suitable solvent 
than injected directly [11] or by headspace sampling [12]. Headspace 
sampling is preferred due to its ability to avoid direct liquid or solid 
probing. In the headspace sampling, complex sample matrix in a solid 
or liquid sample matrix in the liquid or solid sample can be simplified 
or even eliminated in its vapor phase [13].
The methods reported for quantitative determination 
of paroxetine in tablets and/or biological fluids include 
voltammeter [14,15], densitometry [16,17], high-performance liquid 
chromatography [18-23], gas chromatography[24-26], and capillary 
electrophoresis [27].
The objective of this work is to develop and validate a new gas 
chromatographic method for the simultaneous determination of 
acetone and isopropyl alcohol in paroxetine. These solvents should 
be estimated and checked so that they may not exceed the amount 
specified by the ICH guidelines.
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EXPERIMENTAL WORK
Materials and reagents
Paroxetine raw material was procured from Spectrum Pharma Research 
Private Limited, Hyderabad. GC grade acetone, isopropyl alcohol, 1-propanol, 
(Table 1)and N, N-dimethylacetamide were purchased from Merck (India).
General procedure
Instrumentation
A gas chromatograph (Agilent Technologies 7890A) equipped with flame 
ionization detector (FID) connected to Agilent G1888 Headspace sampler 
and a data processor Waters Empower three software was employed.
Method optimization
Various GC columns such as DB-1 and DB-5 were used of various 
dimensions, but the best separation was achieved on ZB-1, 30 m length 
x 0.53 mm ID, and film thickness 5 µm. Details of other optimized gas 
chromatographic and headspace parameters are given in Table 2 and 
Table 3, respectively. For suitability of a system, tailing factor kept 
was not more than 2.0, theoretical plate count not <5000, and %RSD, 
not more than 10.0%, was kept for peak area of each solvent for six 
standard solution replication injections.
Internal standard solution
Transfer 1.5 mL of 1-propanol into 25 mL volumetric flask containing 
about 10 mL of diluent and made up to mark with diluent. Further, 
dilute 5 mL of the above solution into 200 mL volumetric flask 
containing approximately 100 mL of diluent, mix and made to mark 
with diluent.
Blank solution
Transfer 5 mL of internal standard solution into Agilent Technologies 
manufactured 20 mL flat bottom headspace GC vials fitted with a 
septum and crimp cap, and seal. The chromatogram of blank solution 
showed in Fig. 2.
Standard stock solution
Accurately weighed 200 mg of acetone and 200 mg of isopropyl alcohol 
were added to a 20 mL volumetric flask containing about 10 mL of 
internal standard solution.
Pipette 2 mL of this solution into a 100 mL volumetric flask containing 
about 50 mL of internal standard solution. Makeup to the required 
volume with internal standard solution and mix.
Pipette 5 mL of this solution into 20 mL headspace GC vial and seal vial 
adequately fitted with a septum and crimp cap. This should be repeated 
6 times.
This standard solution contains about 5000 ppm of acetone and 
5000 ppm of isopropyl alcohol. The chromatogram of standard solution 
Showed in Fig. 3.
Fig. 3: Typical chromatogram of standard solution
Table 1: Residual solvent with their class and limits
Solvent Class Limit (ppm)
Acetone 3 5000
Isopropyl alcohol 3 5000
Table 2: Optimized gas chromatographic conditions
Parameter Condition
Carrier gas Helium




Carrier gas mode Split
Split ratio 1:10










Run time 24 min
Oven temperature T1 40°C; hold for 12 min
T2 220°C at the rate of 30°C/min; hold for 6 min
FID: Flame ionization detector
Fig. 1: Structure of paroxetine
Fig. 2: Typical blank chromatogram
Table 3: Optimized headspace conditions
System parameter Optimum conditions
Oven temperature 90°C
Loop temperature 100°C
Transfer line temperature 120°C
GC cycle time 35 min
Vial equilibration time 20 min
Vial pressurization time 0.5 min
Loop fill time 0.5 min
Loop equilibration time 0.05 min
Injection time 1.0 min
Vial agitation Low
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Sample preparation
Weigh accurately 200 mg of tablets crushed powder into 20 mL flat 
bottom headspace GC vials; add 5 mL of internal standard solution 
fitted with a septum and crimp cap and seal.
METHOD DEVELOPMENT AND VALIDATION
System suitability
System performance parameters of the optimized GC method were 
determined by analyzing standard solution. Chromatographic 
parameters such as plate count, asymmetry, and resolution were 
determined. The results are within the specifications, indicating 
the excellent performance of the system. System repeatability was 
established by six replicate injections of the standard solution, and the 
relative standard deviations (RSD) for the peak area ratio of the solvents 
were calculated to evaluate the repeatability. The obtained results were 
within the ICH permissible limits mentioned in Table 4. The blank 
chromatogram is shown in Fig. 2, and the typical chromatogram shows 
that all the solvents are shown in Fig. 3.
Linearity
The linearity of the relationship between the peak area ratio and the 
concentration in ppm evaluated for all the residual solvents mentioned 
in the present study was investigated by linear regression analysis. Six 
linearity solutions were prepared to range from limit of quantitation 
(LOQ) to 150% of the limit level concentration of each solvent. The 
linear range investigated for each solvent is mentioned in Table 5. 
Linearity curves were drawn by plotting the graph of the average peak 
area ratio of solvent against its concentration in ppm for linearity 
solutions, Figs. 4 and 5.
Accuracy and precision
Both the terms accuracy and precision are mutually correlated, where 
accuracy is the difference between the true value and the observed 
value. With the precision, it has a limited significance. Accuracy and 
precision were determined by applying the optimized method in which 
known amount of each solvent corresponding to LOQ, 50%, 100%, and 
150% of target concentration. Each level was prepared in triplicate. The 
accuracy was then calculated as the percentage of analyte recovered. 
From the results, it is evident that the recovery of each in spiked 
samples ranged from 97.0% to 115.0%. Mean recoveries for paroxetine 
are shown in Table 6. The precision of an analytical procedure 
expresses the closeness of agreement (degree of scattering) between 
a series of measurements obtained from multiple sampling of the 
same homogeneous sample under the prescribed conditions Table 7. 
Fig. 4: Linearity graph of acetone
Fig. 5: Linearity graph of isopropyl alcohol
Table 5: Linearity and range of solvents
S.No Percentage level Acetone Isopropyl alcohol
Concentration (μg/mL) Mean peak area ratio Concentration (μg/mL) Mean peak area ratio
1 LOQ 80.96 0.031 251.39 0.029
2 50 2500.75 0.881 2507.62 0.266
3 75 3751.12 1.328 3761.43 0.401
4 100 5001.5 1.777 5015.24 0.537
5 125 6251.87 2.133 6269.06 0.645
6 150 7502.25 2.667 7522.87 0.806
Table 4: Results of system suitability study
System suitability parameters Observed value Acceptance criteria
Acetone Isopropyl alcohol
Retention time 9.210 9.845 For information
Percentage RSD for area count of six replicate injection of standard 2.5 0.5 NMT 10.0
Tailing factor 1.1 1.1 NMT 2.0
Theoretical plates 58421 24813 NLT 2000
Resolution 2.3 NLT 1.5
RSD: Relative standard deviations, NLT: Not less than, NMT: Not more than
Precisions may be considered at three levels: repeatability, intermediate 
precision, and reproducibility. The precision of an analytical procedure 
is usually expressed as the variance, standard deviation, or coefficient 
of variation of a series of measurements. Method precision shall be 
established by determining the assay in six different preparations of 
a standard solution. Intermediate precision shall be determined by 
studying the variation in assay of a homogeneous sample analyzed 
by two different equipment, analyst, and days. The average, standard 
deviation, and relative standard deviation shall be calculated. The 
results for the method and intermediate precision are found to be under 
the acceptable limit for each residual solvent as revealed by relative 
standard deviation data (RSD <5.0% for the solvents). The precision 
results are shown in Table 8.
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Limit of detection (LOD) and limit of quantitation (LOQ)
The limit of detection of an individual analytical procedure is the lowest 
amount of analyte in a sample, which can be detected but not necessarily 
quantitated as an exact amount. While the limit of quantitation was 
the minimum level of concentration of analyte at which it can be 
quantitated with acceptable precision and accuracy. LOD and LOQ 
were calculated using the signal-to-noise ratio (S/N) method using 
the Empower software. Six replicate solutions were injected into the 
chromatograph and recorded. Obtained LOD and LOQ of each solvent 
are mentioned in Table 9.
Robustness
For robustness, three deliberate changes were done concerning carrier 
gas flow rate, column oven temperature, and vial oven temperature. 
Each change consists of one upper set and one lower set. For each set, 
six replicate determinations were analyzed. The results were found to 
be satisfactory and within the acceptable limits. The obtained results 
are mentioned in Tables 10 and 11.
RESULTS AND DISCUSSION
The retention time of the solvent peak of standard solution matches 
with that of the spiked test sample solution. No interference was 
observed at a retention time of the solvent peak from blank and 
test sample. The percentage recovery obtained for each solvent 
was in the range of 80%–120%, which is within ICH acceptance. 
Precision parameter shows that the RSD was <5.0% for all the 
solvents in system precision, repeatability, and intermediate 
precision at 100% concentration. Linearity was observed in 
the concentration range of LOQ to 150% with r2 values >0.999 
and y-intercept <5.0% showing a good correlation between 
the response and solvent concentration. The calculated limit of 
detection and limit of quantitation for each solvent found to be 
Table 6: Results of recovery study for acetone
S.No Recovery level (%) Amount added (µg/ml) Amount recovered (µg/ml) Recovery (%)
1 LOQ 80.96 87.48 108.05
84.66 104.57
93.13 115.03
2 50 2500.75 2449.55 97.95
2460.84 98.40
2548.32 101.90
3 100 5001.5 4901.92 98.01
4924.5 98.46
5099.46 101.96
4 150 7502.25 7351.47 97.99
7388.16 98.48
7647.79 101.94
LOQ: Limit of quantitation
Table 8: Results of precision study for acetone and isopropyl alcohol
Parameter Percentage RSD
Acetone Isopropyl alcohol
System precision (standard solution) (peak area ratio) 2.53 0.54
Precision at LOQ (peak area ratio) 3.22 2.46
Repeatability (intraday) (content ppm) 0.93 0.73
Intermediate precision (interday) (content ppm) 0.69 0.65
Cumulative (intraday and interday) (content ppm) 0.83 0.67
RSD: Relative standard deviations, LOQ: Limit of quantitation




LOD (μg/mL) S/N LOQ (μg/mL) S/N
1 Acetone 26.72 3.9 80.96 10.2
2 Isopropyl 
alcohol
82.96 4.3 251.39 11.2
LOD: Limit of detection, LOQ: Limit of quantitation, S/N: Signal-to-noise ratio
Table 7: Results of recovery study for isopropyl alcohol
S.No Recovery level (%) Amount added (µg/ml) Amount recovered (µg/ml) Recovery (%)
1 LOQ 251.39 269.34 107.14
278.62 110.83
287.91 114.53
2 50 2507.62 2498.33 99.63
2498.33 99.63
2507.62 100.0
3 100 5015.24 4996.67 99.63
4996.67 99.63
5005.96 99.81
4 150 7522.87 7495.0 99.63
7495.0 99.63
7513.58 99.88
LOQ: Limit of quantitation
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satisfactory. The method is robust as in robustness parameter 
with deliberate changes made for which individual and cumulative 
RSD values for each set were <5.0%.
CONCLUSION
The developed GC method with FID detector offers simplicity, 
selectivity, precision, and accuracy. It produces symmetric peak shape 
and reasonable retention time for various solvents. It can be seen from 
the chromatogram that all the solvents were eluted before 20 min of 
injection of sample. It can be used for the determination of residual 
solvents in paroxetine API and also in the finished dosage forms 
where the particular solvents used for the coating purpose in the 
pharmaceutical companies and research laboratories.
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